Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
06/2011
06/15/2011EP2332533A1 Cannabinoid-containing plant extracts as neuroprotective agents
06/15/2011EP2332531A1 Apo2 ligand/TRAIL formulations
06/15/2011EP2332523A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
06/15/2011EP2332424A1 Method for producing lipid
06/15/2011EP2331578A1 Novel compositons and methods for treating ige-mediated disorders
06/15/2011EP2331541A1 Indolizine inhibitors of leukotriene production
06/15/2011EP2331526A2 Pyrimidine derivatives as kinase inhibitors
06/15/2011EP1784399B1 Pyrimidine derivatives
06/15/2011EP1389618B1 Pyrazolo 1,5-a pyridines and medicines containing the same
06/15/2011EP1131080B2 Selection and uses of lactic acid bacteria strains modulating non-specific immunity
06/15/2011EP1052254B1 Nitrogenous heterocyclic derivatives and medicine thereof
06/15/2011EP0939804B2 NEUTROKINE alpha
06/15/2011CN201861992U Multiple coating mirco-capsulation lactic acid bacteria (MCM-LAB) structure
06/15/2011CN1849135B Methods for treating interleukin-6-related diseases
06/15/2011CN1452636B Human monoclonal antibodies to dendritis cells
06/15/2011CN102099471A Aptamer against il-17 and use thereof
06/15/2011CN102099374A Methods and compositions for modulating angiogenesis and pericyte composition
06/15/2011CN102099342A Aminotetrahydroindazoloacetic acids
06/15/2011CN102093598A Composite edible fungi polysaccharides and preparation method thereof
06/15/2011CN102093460A Triterpenoid saponin compound as well as synthesis method and application of triterpenoid saponin
06/15/2011CN102093452A Hydrogenation type ginsenoside aglycons as well as preparation method and application of hydrogenation type ginsenoside aglycons
06/15/2011CN102093421A Phosphorus substituent group-containing quinoline compound and preparation method of quinoline compound as well as pharmaceutical composition containing quinoline compound and application of pharmaceutical composition
06/15/2011CN102093380A Cyclic icaritin aglycon as well as preparation method and application of cyclic icaritin aglycon
06/15/2011CN102093373A Compounds formed by structural modifiecation of sinomenine and preparation method thereof
06/15/2011CN102093364A 2,4-diamido-6,7-dihydro-5H-pyrrolo [2,3] pyrimidine derivative as focal adhesion kinase/pyruvate kinase 2 (FAK/Pyk2) inhibitor
06/15/2011CN102093363A Pyrrolo-triazine aniline compounds useful as kinase inhibitors
06/15/2011CN102093250A Glutamine dipeptide compound and novel method thereof
06/15/2011CN102093187A Polyketone compounds and application thereof
06/15/2011CN102091317A Qi-tonifying desensitizer and use thereof
06/15/2011CN102091277A Negative ion far-infrared immune synergist with nano-selenium and germanium and traditional Chinese medicine elements
06/15/2011CN102091268A Medicament for treating allergic rhinitis and preparation method thereof
06/15/2011CN102091220A Traditional Chinese medicine for treating endogenous heat disease
06/15/2011CN102091216A Process for processing aloe juice
06/15/2011CN102091152A Traditional Chinese medicinal composition with stomach-invigorating and digestion-promoting function and preparation method thereof
06/15/2011CN102091148A Coating method for miraculous pill of ledebouriella
06/15/2011CN102091133A Nano selenium-germanium snake anion far infrared body-building life-prolonging health-care drink
06/15/2011CN102091132A Method for detecting esculin, aesculetin, fraxin and fraxetin in cortex fraxini or extract thereof
06/15/2011CN102091100A Method for improving main medicinal ingredients through solid fermentation of Indian buead and cordyceps militaris
06/15/2011CN102091089A Application of active burdock oligosaccharide to aquaculture
06/15/2011CN102091014A Strengthened nanometer element traditional Chinese medicine anion far infrared functional perfume
06/15/2011CN102091006A Tea extract facial cleanser and preparation method thereof
06/15/2011CN102090636A PUFA supplements
06/15/2011CN102090629A Dual-purpose food--medicament product capable of delaying aging and preparation method thereof
06/15/2011CN102090622A Sparassia crispa(Wulf.)Fr. solution preparation method
06/15/2011CN102090560A Synergism of GOS and polyfructose
06/15/2011CN102090558A Composition containing probiotics, DHA (docosahexaenoic acid) and lactoferrin and applications thereof
06/15/2011CN102090532A Immunopotentiator for large yellow croaker juvenile
06/15/2011CN101732362B Application of wild truffle in preparing medicine with anticancer and immunological functions
06/15/2011CN101716158B Method for preparing matrine slow-release tablet by applying attapulgite
06/15/2011CN101618050B Compound fungus polysaccharide with function of enhancing immunity and application thereof
06/15/2011CN101584766B Compound schizonepeta Chinese medicinal soup used for treating urticaria
06/15/2011CN101530443B Asarum volatile oil prepared by system solvent method and use thereof
06/15/2011CN101507734B Deer-bone serial processing method
06/15/2011CN101407554B Sodium carboxymethylstarch and preparation thereof
06/15/2011CN101322810B Chinese traditional medicine composition for treating diabetes respiratory tract infection
06/15/2011CN101301316B Compound formulation containing lactobacillus leavening and preparation and use thereof
06/15/2011CN101229320B Glutathione ammoniacum compounds and processing method thereof
06/15/2011CN101194919B Hippophae rhamnoides seed oil fatty milk injection and technique of preparing the same
06/15/2011CN101130515B Substituted-1H- indoles compound, method for preparing the same, application and pharmaceutical composition of the same
06/15/2011CN101111495B Crystalline 1h-imidazo[4,5-b]pyridin-5-amine, 7-[5-[(cyclohexylmethylamino)-methyl]-1h-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its pharmaceutical uses
06/15/2011CN101056855B Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
06/15/2011CN101044120B Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
06/15/2011CA2725435A1 Vaccines for inclusion body hepatitis
06/14/2011US7960570 Small molecule inhibitors of rotamase enzyme activity
06/14/2011US7960433 Treatment of chemokine mediated diseases
06/14/2011US7960416 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization
06/14/2011US7960407 Crystal forms of an imidazole derivative
06/14/2011US7960397 6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions
06/14/2011US7960395 5,7-disubstituted thiazolo[4,5-d]pyrimidines for the selective inhibition of chemokine receptors
06/14/2011US7960369 Receptor function regulator
06/14/2011US7960366 Substituted tetracycline compounds as synergistic antifungal agents
06/14/2011US7960351 Method for producing pectin hydrolysis products
06/14/2011CA2496676C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
06/14/2011CA2494962C Tyrosine kinase inhibitors
06/14/2011CA2451859C Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain
06/14/2011CA2430669C Synthesis of 3-amino-thalidomide and its enantiomers
06/14/2011CA2428468C New 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
06/14/2011CA2426292C Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression
06/14/2011CA2382331C Vaccine against intra-cellular pathogens
06/14/2011CA2327389C Dna vaccine for horses containing as at least one adjuvant, polymers of acrylic or methacrylic acid, or copolymers of maleic anhydride and ethylene
06/14/2011CA2301327C Use of herpes vectors for tumor therapy
06/14/2011CA2200540C Use of l-carnitine or derivatives thereof and antioxidants for the prevention and treatment of diseases elicited by oxidative stress to the nervous and cardiovascular system
06/09/2011WO2011068953A2 Atoxic recombinant holotoxins of clostridium difficile as immunogens
06/09/2011WO2011068853A2 TREATMENT OF IgE-MEDIATED DISEASE
06/09/2011WO2011068233A1 Imidazoquinolines which act via toll - like receptors (tlr)
06/09/2011WO2011068226A1 Macrophage phagocytosis-activating composition and/or composition promoting cytokine production in macrophages
06/09/2011WO2011068171A1 Bicyclic nitrogen-containing saturated heterocyclic derivatives
06/09/2011WO2011067560A1 Combination of droloxifene and clopidogrel
06/09/2011WO2011067366A1 Indazole derivatives as pi 3 - kinase inhibitors
06/09/2011WO2011050054A3 Coumarin compounds as receptor modulators with therapeutic utility
06/09/2011WO2011041886A8 Vaccines comprising heat-sensitive transgenes
06/09/2011US20110136922 Activation induced deaminase (aid)
06/09/2011US20110136911 Treatment of sepsis and inhibition of mif by d-t4
06/09/2011US20110136869 Compounds Which Selectively Modulate The CB2 Receptor
06/09/2011US20110136860 Compounds
06/09/2011US20110136857 Pyrrole[2,3-b]pyridine derivatives active as kinase inhibitors
06/09/2011US20110136834 Inhibitors of e1 activating enzymes
06/09/2011US20110136816 Compounds that modulate intracellular calcium
06/09/2011US20110136796 IDO Inhibitors
06/09/2011US20110136790 Tricyclic Heterocyclic Derivatives and Methods of Use